Company Number: 15264835

Analysis Date: 2025-07-29 12:43 UTC

Financial Health Assessment for LAB BLADES LTD

---

1. Financial Health Score: B

Explanation:
LAB BLADES LTD shows a stable financial position for a newly incorporated micro-entity. The company has positive net assets and working capital, indicating a healthy liquidity position and initial capitalization. However, given its very recent establishment (less than 1.5 years), limited fixed assets, and modest scale, there is some natural caution warranted. Hence, a solid "B" grade reflects good early-stage financial health with room to strengthen operational cash flow and asset base.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets	2,507	Low fixed asset base typical of a start-up; limited long-term investment so far.
Current Assets	13,733	Short-term resources including cash and receivables, adequate for operational needs.
Current Liabilities	11,194	Short-term debts and payables; manageable given current assets.
Net Current Assets (Working Capital)	2,539	Positive working capital indicates the company can cover its short-term obligations, a sign of healthy liquidity.
Total Assets less Current Liabilities	5,046	Reflects net asset value after covering short-term debts; positive and balanced.
Net Assets (Shareholders’ Funds)	5,046	Equity funded by owner; indicates capitalization and no accumulated losses.
Employee Count	5	Small team consistent with micro-entity status.
Account Category	Micro	Minimal reporting requirements; suitable for early-stage companies.

What these Vital Signs Indicate:

• The company is solvent with sufficient liquidity to meet immediate liabilities.
• The equity base is intact, showing no signs of financial distress or erosion.
• Asset composition dominated by current assets suggests operational focus rather than capital-intensive investment.
• The positive working capital is akin to a "healthy pulse," demonstrating the business can sustain day-to-day functions without liquidity strain.

---

3. Diagnosis: Financial Health and Business Condition

LAB BLADES LTD is in the early stages of its business life cycle, showing the "vital signs" of a healthy startup. The positive net current assets and net assets indicate no immediate financial distress or solvency issues. The modest asset base and capital structure reflect prudent initial funding and low risk exposure.

The company operates in specialised design and motor vehicle parts retail and maintenance—sectors where initial asset needs can be modest but operational liquidity is crucial. The current figures reveal strong short-term financial management with no symptoms of over-leverage or cash flow weakness.

Given the limited history, the absence of audit requirements, and micro-entity status, the company is unlikely to face complex financial compliance risks at this stage. The director's involvement and ownership concentration (75-100% control) suggest clear governance but also a dependence on key person decisions and capital injection.

Potential symptoms to monitor:

• Growth in liabilities without corresponding asset increase (could indicate liquidity stress).
• Absence of profit and loss data limits insight into operational profitability—a critical next step.
• Limited fixed assets may constrain scalability or operational efficiency.

---

4. Recommendations: Steps to Enhance Financial Wellness

• Improve Cash Flow Monitoring: Establish detailed cash flow forecasting to ensure continued "healthy circulation" of funds, especially as the business scales.
• Build Fixed Asset Base Strategically: Consider investing gradually in fixed assets (equipment, technology) to support operational capacity and long-term value.
• Profitability Tracking: Implement robust profit and loss tracking to identify revenue streams and cost drivers, ensuring sustainable earnings.
• Maintain Strong Working Capital: Keep a close watch on current liabilities to avoid liquidity "blockages" that could strain operations.
• Governance and Succession Planning: With a single controlling director, consider planning for governance diversification to mitigate key person risk.
• Timely Compliance: Continue prompt filing of accounts and confirmation statements to avoid penalties and maintain corporate health signals.

---